2
Clinical Trials associated with Influenza Vaccine (Split Virion), Inactivated (CuroVax)评价流感病毒裂解疫苗在中国6月龄及以上健康受试者中免疫原性和安全性的随机、盲态、阳性对照临床试验
[Translation] A randomized, blinded, positive-controlled clinical trial to evaluate the immunogenicity and safety of influenza virus split vaccine in healthy Chinese subjects aged 6 months and above
评价江苏先声卫科生物制药有限公司生产的流感病毒裂解疫苗在6月龄及以上常住健康人群中的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of the influenza virus split vaccine produced by Jiangsu Simcere Biopharmaceutical Co., Ltd. in healthy residents aged 6 months and above.
评价流感病毒裂解疫苗在中国6月龄及以上健康受试者中免疫原性和安全性的随机、盲态、阳性对照临床试验
[Translation] A randomized, blinded, positive-controlled clinical trial to evaluate the immunogenicity and safety of influenza virus split vaccine in healthy Chinese subjects aged 6 months and above
评价江苏先声卫科生物制药有限公司生产的流感病毒裂解疫苗在6月龄及以上常住健康人群中的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of influenza virus split vaccine produced by Jiangsu Simcere Biopharmaceutical Co., Ltd. in healthy residents aged 6 months and above.
100 Clinical Results associated with Influenza Vaccine (Split Virion), Inactivated (CuroVax)
100 Translational Medicine associated with Influenza Vaccine (Split Virion), Inactivated (CuroVax)
100 Patents (Medical) associated with Influenza Vaccine (Split Virion), Inactivated (CuroVax)
100 Deals associated with Influenza Vaccine (Split Virion), Inactivated (CuroVax)